Outcomes of Concomitant Autoimmune Diseases in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Key Points

• Outcomes are significantly affected by the presence of autoimmune diseases, complicating treatment.
• Incidence of graft-versus-host disease increases in these patients, indicating higher risks.
• Analysis of clinical data from transplantation centers highlights the challenges faced by affected individuals.
• Understanding complications related to autoimmune diseases is crucial for better patient care and management.